Gilead Sciences, Inc. (NEO:GILD)
26.25
+0.17 (0.65%)
Nov 26, 2025, 3:59 PM EST
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of CAD 218.12 billion as of November 28, 2025. Its market cap has increased by 29.61% in one year.
Market Cap
218.12B
Enterprise Value
238.18B
Revenue
40.51B
Ranking
n/a
PE Ratio
19.31
Stock Price
26.25
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 289.43M to 218.12B, an increase of 75,260.55%. That is a compound annual growth rate of 21.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 222.31B | 34.22% |
| Dec 31, 2024 | 165.64B | 24.25% |
| Dec 29, 2023 | 133.31B | -8.53% |
| Dec 30, 2022 | 145.73B | 26.44% |
| Dec 31, 2021 | 115.26B | 23.86% |
| Dec 31, 2020 | 93.06B | -12.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.46B |
| dentalcorp Holdings | 2.18B |
| Sienna Senior Living | 1.97B |
| Green Thumb Industries | 1.91B |
| Extendicare | 1.75B |
| Cronos Group | 1.33B |
| Trulieve Cannabis | 1.29B |
| WELL Health Technologies | 967.29M |